Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of targeted therapies and immunotherapies in the management of progressive glioblastoma.
Evan WinogradIsabelle GermanoPatrick WenJeffrey J OlsonDavid Ryan OrmondPublished in: Journal of neuro-oncology (2021)
There is insufficient evidence to support a recommendation regarding this question.